xanthenes has been researched along with amyloid beta-peptides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audia, JE; Drzewiecki, GJ; Fuson, K; Hyslop, PA; May, PC; Rydel, RE; Wogulis, M; Wright, S; Zhang, Z | 1 |
| Chen, K; Cheng, AC; Dineen, TA; Epstein, O; Fremeau, RT; Graceffa, R; Hickman, D; Huang, H; Kiang, YH; La, DS; Louie, S; Luo, Y; Patel, VF; Wahl, RC; Wen, PH; Whittington, DA; Wood, S | 1 |
2 other study(ies) available for xanthenes and amyloid beta-peptides
| Article | Year |
|---|---|
Amyloid beta-mediated oxidative and metabolic stress in rat cortical neurons: no direct evidence for a role for H2O2 generation.
Topics: Adenosine Triphosphate; Amyloid beta-Peptides; Analysis of Variance; Animals; Benzothiazoles; Catalase; Cell Survival; Cells, Cultured; Cerebral Cortex; Coloring Agents; Fetus; Fluoresceins; Free Radical Scavengers; Glucose; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycolysis; Glyoxylates; Hydrogen Peroxide; L-Lactate Dehydrogenase; Neurons; Neurotoxins; Oxazines; Oxidative Stress; Peptide Fragments; Rats; Reactive Oxygen Species; Thiazoles; Xanthenes | 1996 |
Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain; Cell Line; Crystallography, X-Ray; Drug Design; Humans; Models, Molecular; Molecular Structure; Oxazoles; Peptide Fragments; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Xanthenes | 2012 |